Matthew L. Sherman, EVP & Chief Medical Officer: Deciphera Pharmaceuticals DCPH Sell · Filed 23/01/19

Trade details

Type: Insider sale
Amount: $51,039.72
Shares · price: 2,403 sh · $21.24 a share
Held after: 72,628 sh
Stock: Deciphera Pharmaceuticals DCPH
Person: Matthew L. ShermanEVP & Chief Medical Officer
Trade date: 23/01/17
Filed: 23/01/19
Days to filing: 2 days

Sold 3.2% of holdings

Share of holding sold: 3.2%

Deciphera Pharmaceuticals trades, last 26 weeks

What else happened in Deciphera Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 22/12/18~23/02/16

Matthew L. Sherman's recent trades

Matthew L. ShermanEVP & Chief Medical Officer
SellDeciphera Pharmaceuticals
Sell
Deciphera Pharmaceuticals
DCPH
$40.8K
2,615 sh
$40.8K
Filed 24/02/20
Traded 24/02/16
Matthew L. ShermanEVP & Chief Medical Officer
SellDeciphera Pharmaceuticals
Sell
Deciphera Pharmaceuticals
DCPH
$35.2K
2,435 sh
$35.2K
Filed 24/01/18
Traded 24/01/16
Matthew L. ShermanEVP & Chief Medical Officer
SellDeciphera Pharmaceuticals
Sell
Deciphera Pharmaceuticals
DCPH
$42.9K
2,792 sh
$42.9K
Filed 23/12/14
Traded 23/12/13
Matthew L. ShermanEVP & Chief Medical Officer
SellDeciphera Pharmaceuticals
Sell
Deciphera Pharmaceuticals
DCPH
$28.4K
2,360 sh
$28.4K
Filed 23/10/31
Traded 23/10/30
Matthew L. ShermanEVP & Chief Medical Officer
SellDeciphera Pharmaceuticals
Sell
Deciphera Pharmaceuticals
DCPH
$37.3K
2,942 sh
$37.3K
Filed 23/10/04
Traded 23/10/02